Prudential Financial
UBX

Prudential Financial’s Unity Biotechnology UBX Stock Holding History

Prudential Financial’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,160
Closed -$33.6K – 2699
2023
Q2 		$33.6K Hold
13,160
– – ﹤0.01% 2570
2023
Q1 		$21.5K Hold
13,160
– – ﹤0.01% 2565
2022
Q4 		$36.1K Buy
13,160
+7,600
+137% +$22.1K ﹤0.01% 2525
2022
Q3 		$22K Buy
+5,560
New +$35.1K ﹤0.01% 2627

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prudential Financial's UBX Position: Q3 2023 in Review

Prudential Financial sold out of Unity Biotechnology (UBX) in Q3 2023, closing a stake of 13,160 shares — an estimated $33.6K sold.

Prudential Financial first reported a position in UBX in Q3 2022 and held it in 4 quarters. The position peaked at $36.1K in Q4 2022. 36 funds tracked by Wall St. Rank hold UBX as of Q3 2023.

  • Prudential Financial reported no remaining Unity Biotechnology position as of Q3 2023 after selling out during the quarter.
  • Prudential Financial sold 13,160 Unity Biotechnology shares in Q3 2023, an estimated $33.6K.
  • Prudential Financial first reported a position in Unity Biotechnology in Q3 2022 and held it in 4 quarters.
  • Prudential Financial's Unity Biotechnology position peaked at $36.1K in Q4 2022.
  • 36 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2023.

Based on Prudential Financial's 13F filing for Q3 2023, filed 13 Nov 2023.